Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Special NoticeNo Set AsideActive
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Bethesda, MD
- Industry: Testing Laboratories and Services
Contract Details
- Notice ID
- NOI-PCA-NIDA-09054
- Opportunity Type
- Special Notice
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH
- Posted Date
- Tuesday, September 8, 2026
- Response Deadline
- Tuesday, September 15, 2026
- PSC Code
- Q301
- Set-Aside
- No Set Aside
- Place of Performance
- Bethesda, MD, 20892
- Status
- Active
Description
Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for testing laboratories and services with a set-aside for No Set Aside businesses in Bethesda, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts